Stephens »

Halozyme Therapeutics shares owned by Stephens

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Stephens from 13F filings

Historical chart of Stephens investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Stephens consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Stephens

Quarter filed Position value Share count Share price at filing
2025-12-31 $57k 53k 1.08
2025-09-30 $61k 53k 1.14

More positions owned by Stephens

Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Wal-Mart Stores (WMT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Rus Mdcp Val Etf (IWS)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Stephens

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation
Ameriprise Financial
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
FMR

View all funds holding Halozyme Therapeutics